<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To observe the effect of Huancongdan (HCD) capsule on senile vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Seventy two cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVD</z:e> were divided randomly into two groups </plain></SENT>
<SENT sid="2" pm="."><plain>The HCD group (37 cases) were treated with HCD and the control group (35 cases) treated with Hydergine </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: After 2 months of treatment, the clinical symptoms, hyponeural defect, self-care capability and abnormal ratio of whole blood viscosity to plasma viscosity in HCD group were significantly different as compared with before treatment (P &lt; 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSION: The effect of HCD for treatment of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVD</z:e> was affirmative </plain></SENT>
</text></document>